Brought to you by:
Diversity efforts while in training: Is it just another box to check?
2020 was a herald year. It ushered in a global pandemic and a reckoning with issues of diversity, equity and inclusion (DEI) in our workspaces. Vascular surgery, by nature of the diseases we encounter and our longitudinal relationship with our…
Community practice award deadline extended
There’s still time! The Society for Vascular Surgery (SVS) has extended the deadline to nominate an SVS member for the prestigious Excellence in Community Practice Award. Applications now are being accepted through March 31 for this award, formerly known as…
From the SVS journals
The Journal of Vascular Surgery Cases, Innovations and Techniques has been growing rapidly, publishing an estimated 33% more articles this year than two years ago, according to JVS editors Peter Lawrence, MD, and Peter Gloviczki, MD. “In 2021, we modified…
Silence is golden—but does self-imposed silence lead to burnout?
Burnout is associated with silence in various contexts. It is called the silent crisis, the silent epidemic, or the silent killer. What is not talked about is the pressure or fear at work, whether professional or personal, that can lead…
First patient enrolled in PEERLESS study of FlowTriever system
Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomized controlled trial (RCT) comparing the outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever system versus catheter-directed thrombolysis (CDT). The first…
New data add to body of evidence highlighting ‘importance’ of vascular surgery in trauma center setting
Another study has emerged showing vascular surgery’s heavy intraoperative consult activity in a level 1 trauma center setting, lending further fuel to the “vascular firefighter” analogy. A research team that included fourth-year medical student Abigail Hatcher, MS, of Emory University…
Complex TAAA: US ARC IDE registry reports better survival vs. real-world data after endovascular repair
Patients treated in Food and Drug Administration (FDA)-approved investigational device exemption (IDE) trials for complex thoracoabdominal aortic aneurysms (TAAAs) in the U.S. Aortic Research Consortium (ARC) had better 30-day and one-year survival compared with those recorded in the real-world Vascular…
Apply for VAM travel scholarships by March 9
Medical students and general surgery residents have until March 9 to apply for Society for Vascular Surgery (SVS) travel scholarships that enable attendance at the 2022 Vascular Annual Meeting (VAM) in Boston this June. The scholarships are the SVS General…
March 1 awards deadline nears
The deadline is March 1 for several awards and honors from the Society for Vascular Surgery (SVS) and the SVS Foundation. They include the SVS Lifetime Achievement Award, the Medal for Innovation in Vascular Surgery, the Distinguished Fellow Designation, as…
Worldwide TCAR analysis provides ‘roadmap’ to evaluate future training approaches
An analysis of the worldwide experience of transcarotid artery revascularization (TCAR) has produced key objective proficiency metrics and an analytic framework to assess adequate training for the procedure. “Training on cadavers or synthetic models achieved clinical outcomes, technical outcomes and…